The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126578601 12657860 1 I 20130816 20160808 20160817 20160817 EXP US-ASTRAZENECA-2016SE86387 ASTRAZENECA 30906.00 DY M Y 0.00000 20160817 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126578601 12657860 1 PS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5, 2 PUFFS TWICE A DAY 3001223C00 21929
126578601 12657860 2 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5, 2 PUFFS TWICE A DAY 3001223C00 21929
126578601 12657860 3 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5, 2 PUFFS TWICE A DAY 3001223C00 21929
126578601 12657860 4 C ALBUTEROL. ALBUTEROL 1 Respiratory (inhalation) NEBULIZER 4 TIMES A DAY 0
126578601 12657860 5 C ALBUTEROL. ALBUTEROL 1 Respiratory (inhalation) NEBULIZER 4 TIMES A DAY 0
126578601 12657860 6 C ALBUTEROL. ALBUTEROL 1 Respiratory (inhalation) NEBULIZER 4 TIMES A DAY 0
126578601 12657860 7 C MIDODRINE MIDODRINE 1 Oral 0 5 MG BID
126578601 12657860 8 C ZETIA EZETIMIBE 1 Oral 0 10 MG QD
126578601 12657860 9 C BABY ASPIRIN ASPIRIN 1 Oral 0 81 MG QD
126578601 12657860 10 C SENNA SENNA LEAFSENNOSIDESSENNOSIDES A AND B 1 Oral TWO TIMES A DAY 0
126578601 12657860 11 C MIRALAX POLYETHYLENE GLYCOL 3350 1 Oral EVERY OTHER DAY 0
126578601 12657860 12 C MELATONIN MELATONIN 1 Oral 0 10 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126578601 12657860 1 Chronic obstructive pulmonary disease
126578601 12657860 2 Asthma
126578601 12657860 3 Bronchiectasis
126578601 12657860 4 Chronic obstructive pulmonary disease
126578601 12657860 5 Asthma
126578601 12657860 6 Bronchiectasis
126578601 12657860 7 Blood pressure abnormal
126578601 12657860 8 Blood cholesterol abnormal
126578601 12657860 9 Anticoagulant therapy
126578601 12657860 10 Faeces soft
126578601 12657860 11 Bowel movement irregularity
126578601 12657860 12 Sleep disorder

Outcome of event

Event ID CASEID OUTC COD
126578601 12657860 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126578601 12657860 Aortic stenosis
126578601 12657860 Bladder cancer
126578601 12657860 Body height decreased
126578601 12657860 Dementia
126578601 12657860 Drug dose omission
126578601 12657860 Gait disturbance
126578601 12657860 Intentional product misuse
126578601 12657860 Pneumonia
126578601 12657860 Product quality issue
126578601 12657860 Renal cancer
126578601 12657860 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126578601 12657860 1 2012 0
126578601 12657860 2 2012 0
126578601 12657860 3 2012 0
126578601 12657860 4 201308 0
126578601 12657860 5 201308 0
126578601 12657860 6 201308 0
126578601 12657860 7 201407 0
126578601 12657860 8 201310 0
126578601 12657860 9 2010 0
126578601 12657860 10 2014 0
126578601 12657860 11 2014 0